REGENXBIO Inc. (RGNX) financial statements (2021 and earlier)

Company profile

Business Address 9600 BLACKWELL ROAD
ROCKVILLE, MD 20850
State of Incorp.
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:523400471176159216
Cash and cash equivalents3387076472554
Short-term investments1372272441146560
Other undisclosed cash, cash equivalents, and short-term investments471041511669102
Receivables43389012
Prepaid expense1166521
Other current assets244111
Other undisclosed current assets(47)(104)(151)(16)(69)(102)
Total current assets:53134533816893118
Noncurrent Assets
Operating lease, right-of-use asset6410
Property, plant and equipment5629291491
Long-term investments and receivables501081741669103
Long-term investments471041511669103
Accounts and financing receivable, after allowance for credit loss3423   
Restricted cash and investments11100 
Other noncurrent assets552100
Total noncurrent assets:1771532063179103
TOTAL ASSETS:708498544199173221
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2718151153
Accounts payable1164521
Accrued liabilities000001
Employee-related liabilities13119631
Taxes payable3 1   
Deferred revenue0 
Debt 2    
Customer advances and deposits  0
Contract with customer, liability1
Other undisclosed current liabilities54147451
Total current liabilities:81342214104
Noncurrent Liabilities
Long-term debt and lease obligation709    
Operating lease, liability709
Liabilities, other than long-term debt457110
Deferred revenue and credits110
Deferred revenue43
Contract with customer, liability3
Deferred rent credit  1
Other liabilities123   
Other undisclosed noncurrent liabilities175 6   
Total noncurrent liabilities:2491413110
Total liabilities:330483516115
Stockholders' equity
Stockholders' equity attributable to parent378450509183162217
Common stock000000
Additional paid in capital667628593371276269
Accumulated other comprehensive income (loss)(0)0(1)(1)(0)(1)
Accumulated deficit(289)(178)(83)(188)(115)(52)
Total stockholders' equity:378450509183162217
TOTAL LIABILITIES AND EQUITY:708498544199173221

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues155352191058
Revenue, net1058
Cost of revenue(44)(8)(10)(2)(1)(2)
Cost of goods and services sold(36)(8) (2)(1)(2)
Gross profit:11127209946
Operating expenses(230)(176)(121)(84)(69)(29)
Other operating income (expense), net 0(0)(0)0 
Other undisclosed operating income  00  
Operating income (loss):(119)(149)88(76)(65)(23)
Nonoperating income135216320
Investment income, nonoperating1049732 
Other nonoperating income     0
Interest and debt expense(1)    (0)
Income (loss) from continuing operations before equity method investments, income taxes:(107)(97)104(73)(63)(23)
Other undisclosed income from continuing operations before income taxes1     
Income (loss) from continuing operations before income taxes:(106)(97)104(73)(63)(23)
Income tax expense (benefit)(5)3(4) 0 
Net income (loss):(111)(95)100(73)(63)(23)
Other undisclosed net income attributable to parent     0
Net income (loss) attributable to parent:(111)(95)100(73)(63)(23)
Preferred stock dividends and other adjustments     (2)
Other undisclosed net income available to common stockholders, basic     1
Net income (loss) available to common stockholders, diluted:(111)(95)100(73)(63)(24)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(111)(95)100(73)(63)(23)
Other comprehensive income (loss)(1)1(0)(1)1(1)
Comprehensive income (loss):(112)(94)100(74)(62)(24)
Other undisclosed comprehensive income, net of tax, attributable to parent     0
Comprehensive income (loss), net of tax, attributable to parent:(112)(94)100(74)(62)(24)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: